Loading…
Cryoport, Inc. is projected to rise to $19.98 by 2027, a +32% move from its current price of $15.09. CYRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $14.78 | $15.10 | $15.43 | +0.07% |
| Aug 3 | $14.66 | $15.11 | $15.57 | +0.13% |
| Aug 4 | $14.57 | $15.12 | $15.69 | +0.20% |
| Aug 5 | $14.50 | $15.13 | $15.79 | +0.26% |
| Aug 6 | $14.43 | $15.14 | $15.88 | +0.33% |
| Aug 7 | $14.38 | $15.15 | $15.96 | +0.40% |
| Aug 8 | $14.33 | $15.16 | $16.04 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.33 | $15.16 | $16.04 | +0.46% |
| Week 2 | $14.06 | $15.23 | $16.50 | +0.93% |
| Week 3 | $13.87 | $15.30 | $16.87 | +1.40% |
| Week 4 | $13.73 | $15.37 | $17.21 | +1.87% |
| Week 5 | $13.61 | $15.44 | $17.52 | +2.34% |
| Week 6 | $13.51 | $15.52 | $17.82 | +2.82% |
| Week 7 | $13.42 | $15.59 | $18.10 | +3.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry.
Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories.
It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services.
The company was founded in 1999 and is based in Brentwood, Tennessee.
Cryoport, Inc. (CYRX) operates in the Industrials sector. It is currently priced at $14.93 with a market cap of $752.51M and holds a rank of 2734.
The stock trades with a 30-day range of $12.93 to $17.23 and shows a near-term technical picture characterized by a bullish sentiment. Key indicators include a 50-day simple moving average at $15.31 and a 200-day simple moving average at $10.99, with near-term support at $14.57 and resistance at $16.57.
A major floor 48.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.2% away) — a key level to hold.
The nearest ceiling, 9.8% above — a clean break opens room to run.
A major ceiling 14.5% above — clearing it would confirm fresh momentum.
Key CYRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CYRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.13 | Sell | $15.24 | Sell |
| MA 10 | $15.54 | Sell | $15.44 | Sell |
| MA 20 | $15.71 | Sell | $15.54 | Sell |
| MA 50 | $15.39 | Sell | $14.88 | Buy |
| MA 100 | $12.70 | Buy | $13.46 | Buy |
| MA 200 | $11.05 | Buy | $11.79 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.45 | Neutral |
| Stoch RSI (14) | 11.46 | Buy |
| CCI (20) | -86.02 | Neutral |
| Williams %R (14) | -90.24 | Info |
| MACD (12,26,9) | -0.17 | Sell |
| ROC (12) | -8.93 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 9.76 | Buy |
| TRIX (15) | 0.15 | Buy |
| Awesome (5,34) | -0.40 | Sell |
| Ultimate (7,14,28) | 30.83 | Neutral |
| Momentum (10) | -1.42 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 14.91 | Buy |
| ADX (14) | 15.64 | Neutral |
| ATR (14) | 0.33 | Info |
The 30-day picture shows bullish sentiment, with RSI(14) at 40 and the price hovering around the near-term moving averages. The SMA50 sits at $15.31, while the SMA200 sits at $10.99, outlining a positive but cautious near-term trajectory. The stock trades within a 30-day range of $12.93 to $17.23, indicating a tight band around the current level.
Support is identified at $14.57 and resistance at $16.57, providing near-term technical landmarks for traders.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.72 | $15.09 | $20.79 | 0% | Neutral | |
| $16.25 | $19.98 | $25.76 | +32% | Bullish | |
| $21.13 | $26.55 | $35.29 | +76% | Bullish | |
| $26.17 | $33.47 | $45.56 | +122% | Bullish | |
| $32.16 | $41.78 | $58.02 | +177% | Bullish | |
| $38.12 | $50.22 | $70.98 | +233% | Bullish | |
| $39.38 | $52.55 | $75.46 | +248% | Bullish | |
| $44.88 | $60.62 | $88.29 | +302% | Bullish | |
| $51.78 | $70.75 | $104.41 | +369% | Bullish | |
| $56.85 | $78.54 | $117.35 | +420% | Bullish | |
| $95.00 | $137.84 | $216.88 | +813% | Bullish | |
| $223.71 | $352.48 | $598.48 | +22.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $7.72 | $15.09 | $18.11 | +0.00% |
| September 2026 | $13.00 | $15.28 | $18.40 | +1.26% |
| October 2026 | $13.56 | $16.03 | $19.47 | +4.89% |
| November 2026 | $14.11 | $16.75 | $20.48 | +4.50% |
| December 2026 | $14.18 | $16.90 | $20.79 | +0.90% |
Click any year to see its month-by-month CYRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CYRX is projected to trade between $7.72 and $20.79, averaging $15.09 — a potential gain of 0% from today's $15.09. A consolidation phase looks the most probable path here.
Cryoport, Inc.'s 2027 outlook centres on $19.98, within a $16.25 to $25.76 range. That is up +32% on the projected 2026 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2028, CYRX could reach as high as $35.29, with a base case around $26.55 and support toward $21.13 — roughly +76% from $15.09. Buyers look set to stay in control over this stretch.
Expect CYRX to range from $26.17 to $45.56 through 2029. The $33.47 average target implies a +122% move from current prices. That is up +26% on the projected 2028 average. Momentum favours further upside here.
The CYRX price prediction for 2030 points to an average of $41.78 (low $32.16, high $58.02) — a potential gain of +177% on today's $15.09. Buyers look set to stay in control over this stretch.
In 2031, CYRX is projected to trade between $38.12 and $70.98, averaging $50.22 — a potential gain of +233% from today's $15.09. That is up +20% on the projected 2030 average. Momentum favours further upside here.
Cryoport, Inc.'s 2032 outlook centres on $52.55, within a $39.38 to $75.46 range. That is up +5% on the projected 2031 average. That marks a +248% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CYRX could reach as high as $88.29, with a base case around $60.62 and support toward $44.88 — roughly +302% from $15.09. Momentum favours further upside here.
Expect CYRX to range from $51.78 to $104.41 through 2034. The $70.75 average target implies a +369% move from current prices. That is up +17% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CYRX price prediction for 2035 points to an average of $78.54 (low $56.85, high $117.35) — a potential gain of +420% on today's $15.09. Momentum favours further upside here.
In 2040, CYRX is projected to trade between $95.00 and $216.88, averaging $137.84 — a potential gain of +813% from today's $15.09. That is up +76% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Cryoport, Inc.'s 2050 outlook centres on $352.48, within a $223.71 to $598.48 range. That is up +156% on the projected 2040 average. That marks a +22.4x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CYRX today (≈ 66.269052 CYRX) could be worth
$23,358.58
+$22,358.58 (+2236%) by 2050 · US Dollar
Based on the average projected CYRX price of $352.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CYRXwould be worth at today's price.
$1,000 invested in CYRX on Jul 31, 2025 (≈ 136.425649 CYRX) would be worth
$2,058.66
+$1,058.66 (+105.9%) today · 2.06× · US Dollar
Based on a CYRX entry price of $7.33 vs. today's $15.09.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.37 | $981.78 | -1.8% |
| 1 month ago | $15.86 | $951.45 | -4.9% |
| 3 months ago | $10.35 | $1,457.97 | +45.8% |
| 6 months ago | $9.62 | $1,568.61 | +56.9% |
| 1 year ago | $7.33 | $2,058.66 | +105.9% |
| All time (5.0y) ago | $61.27 | $246.29 | -75.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CYRX forecast.
Our base-case forecast reaches $30.00 around 2029.
Implied market cap at $30.00: $1.51B
The multi-year forecast depicts a bullish trajectory for Cryoport beyond 2026. The 2026 average price is $14.93, with a 2027 average of $19.80 and a 2028 average of $26.26, rising to a 2030 average of $41.46 and continuing higher through 2050 to an average of $349.41. The implied max prices rise from $20.61 in 2026 to $57.77 in 2030, $216.30 in 2040, and $596.90 in 2050, reflecting substantial upside potential over the long term.
Across the forecast horizon, the implied ROI grows from 0 in 2026 to 32.6 in 2027, then 75.9 in 2028, 121.8 in 2029, 177.7 in 2030, 233.4 in 2031, 248.7 in 2032, 303.5 in 2033, 370.2 in 2034, 420.1 in 2035, 816.1 in 2040, and 2240.3 in 2050. These figures accompany a bullish sentiment from 2027 onward, with sustained gains in subsequent years and notable upside potential for the long horizon. As with all forecasts, these are estimates, not guarantees, and reflect risk and uncertainty alongside potential gains.
Tap a question to reveal the answer.
avg $41.46, min $31.84, max $57.77, ROI 177.7, sentiment BULLISH.
From 2027 onward the forecast shows bullish sentiment with ROI values: 32.6 (2027), 75.9 (2028), 121.8 (2029), 177.7 (2030), 233.4 (2031), 248.7 (2032), 303.5 (2033), 370.2 (2034), 420.1 (2035), 816.1 (2040), and 2240.3 (2050).
Yes—the max forecast by 2035 is $116.51, by 2040 is $216.30, and by 2050 is $596.90.
Current price is $14.93 and market cap is $752.51M.
30-day range is $12.93 to $17.23.
Cryoport, Inc. Community Discussion
0Share your Cryoport, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.